drugset / Trial / NCT00003824

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

NCT00003824

RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether ciprofloxacin is more effective than cephalexin in preventing cancer recurrence in patients who are undergoing surgery to treat bladder cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of ciprofloxacin with that of cephalexin in preventing recurrence of cancer in patients who are undergoing surgery for bladder cancer.

Timeline

Start
1999-04
Primary completion
2001-07
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CEPHALEXIN ANHYDROUS Small molecule 500 mg Oral
Subject Ciprofloxacin Small molecule 500 mg Oral